Metabolic effects of dopamine-agonists treatment among patients with prolactinomas.
Kabootari M, Shirmohammadli H, Golgiri F, Mosalamiaghili S, Khajavi A, Akbari H.
Endocrine. 2023 Mar. 79(3):537-544. PMID: 36352337
Kabootari M, Shirmohammadli H, Golgiri F, Mosalamiaghili S, Khajavi A, Akbari H.
Endocrine. 2023 Mar. 79(3):537-544. PMID: 36352337
Kabootari M, Habibi Tirtashi R, Hasheminia M, Bozorgmanesh M, Khalili D, Akbari H, Roshandel G, Hadaegh F.
Public Health. 2022 Jan. 202:84-92. PMID: 34933204
Esfandbod M, Enshaei M, Monzavi SM, Kabootari M, Behfar M, Hamidieh AA.
Leuk Res. 2021 12. 111:106703. PMID: 34534907
Kabootari M, Asgari S, Ghavam SM, Abdi H, Azizi F, Hadaegh F.
J Transl Med. 2021 06 30. 19(1):277. PMID: 34193200
Akbari H, Ghorbani M, Kabootari M, Mehrjardi AZ, Mohajeri Tehrani MR, Malek M, Khamseh ME.
Br J Neurosurg. 2020 Jun. 34(3):253-257. PMID: 32238018
Kabootari M, Hasheminia M, Azizi F, Mirbolouk M, Hadaegh F.
Cardiovasc Diabetol. 2020 03 30. 19(1):41. PMID: 32228577
Kabootari M, Hasheminia M, Guity K, Ramezankhani A, Azizi F, Hadaegh F.
Atherosclerosis. 2019 09. 288:94-100. PMID: 31352273
Kabootari M, Akbarpour S, Azizi F, Hadaegh F.
Nutr Metab (Lond). 2019. 16:16. PMID: 30858870
Kabootari M, Raee MR, Akbarpour S, Asgari S, Azizi F, Hadaegh F.
BMJ Open. 2018 11 25. 8(11):e023735. PMID: 30478120
Kabootari M, Asgari S, Mansournia MA, Khalili D, Valizadeh M, Azizi F, Hadaegh F.
J Am Heart Assoc. 2018 02 10. 7(4). PMID: 29440011